Skip to Main Content

Paper Details

Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C.
Cancer Res
1
2023
ATP, RAD51B, RAD51C, RAD51C missense variants, RAD51C-/-, RAD51D, XRCC2, XRCC3, breast and ovarian cancer, breast cancer, cancer, cisplatin, deleterious variants, human, missense variants, olaparib, ovarian cancer, protein-truncating variants, reconstituted RAD51C-/- cells, reconstituted human RAD51C-depleted cancer cells, women
Author NameAffiliation
Christopher A HaimanKeck School of Medicine, University of Southern California
Christopher A HaimanKeck School of Medicine, University of Southern California
Peter KraftT.H. Chan School of Public Health, Harvard University
Peter KraftT.H. Chan School of Public Health, Harvard University
Katherine L NathansonUniversity of Pennsylvania
Eric C PolleyUniversity of Chicago
Eric C PolleyUniversity of Chicago
Susan M DomchekUniversity of Pennsylvania
Saravut J WerohaMayo Clinic
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
  • 1 - 11

Datasets

Release 1.2